15 research outputs found
Plasmid-Encoded Regulator of Extracellular Proteases in Bacillus anthracis
Bacillus anthracis Sterne cured of the pXO1 plasmid had enhanced secreted protease activity during the postexponential phase but no change in hemolytic or lecithinase activities. A zymogen profile revealed at least six proteases, including serine, metal, and perhaps cysteine types. There were similar amounts of protease secreted by the closely related species Bacillus cereus and Bacillus thuringiensis, but the patterns differed. Among the pXO1 plasmid-encoded proteins, there is a tetratricopeptide protein designated Cot43 that is related to the Rap proteins of Bacillus subtilis and the PlcR pleiotropic regulator of secreted enzymes and toxins in B. thuringiensis. A disruption of the cot43 gene resulted in overproduction of several proteases to a somewhat greater extent than in the plasmid-cured strain. Transformation of either of these strains with a clone of the cot43 gene resulted in the inhibition of accumulation of some of the proteases and induction of at least one. On the basis of lacZ fusions, transcription of the cot43 gene increased in late exponential cells at the time of protease accumulation. The expression of lacZ fusions to the upstream regions of two B. anthracis extracellular protease genes was greater in the strain with the disruption of cot43 than in the Sterne strain, indicating regulation at the level of transcription. In B. anthracis, a pXO1 plasmid-encoded protein directly modulates or indirectly regulates the transcription of genes for several chromosomally encoded extracellular proteases
Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1)
A direct binding screen of 100 000
sp<sup>3</sup>-rich molecules
identified a single diastereomer of a macrolactam core that binds
specifically to myeloid cell leukemia 1 (MCL1). A comprehensive toolbox
of biophysical methods was applied to validate the original hit and
subsequent analogues and also established a binding mode competitive
with NOXA BH3 peptide. X-ray crystallography of ligand bound to MCL1
reveals a remarkable ligand/protein shape complementarity that diverges
from previously disclosed MCL1 inhibitor costructures
A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1
<div><p>Crystallization of a maltose-binding protein MCL1 fusion has yielded a robust crystallography platform that generated the first apo MCL1 crystal structure, as well as five ligand-bound structures. The ability to obtain fragment-bound structures advances structure-based drug design efforts that, despite considerable effort, had previously been intractable by crystallography. In the ligand-independent crystal form we identify inhibitor binding modes not observed in earlier crystallographic systems. This MBP-MCL1 construct dramatically improves the structural understanding of well-validated MCL1 ligands, and will likely catalyze the structure-based optimization of high affinity MCL1 inhibitors.</p></div
The structure of Apo MBP-MCL1 determined at 1.90 Ă….
<p>(A) The MBP domain (red) is connected by a short GS linker (orange) to MCL1 173–321 (blue). A portion of alpha helix four is not ordered in the structure (red dashed-line). Maltose ligand is shown in yellow. (B) The MCL1 domain is structurally very similar to the NMR structure of Apo-MCL1 (gray).</p
Comparison of PDB 4HW3 and MBP-MCL1 with fragment 4.
<p>The structure of MBP-MCL1 with fragment <b>4</b> (yellow) determined to 2.4 Å (blue) overlaid with the structure of MCL1 171–323 determined at 2.4 Å (PDB ID 4HW3, gray). The carboxylic acid of 4HW3 adopts multiple conformations depending on the chain; only chain A is shown for clarity.</p
MCL1 ligands used in co-crystallization experiments.
<p>MCL1 ligands used in co-crystallization experiments.</p
The structure of MBP-MCL1 bound to fragment 5 determined at 1.9 Ă….
<p>Fragment <b>5</b> (yellow) binds similarly in comparison to the elaborated ligand from PDB ID 4OQ6 (gray).</p
The conformational flexibility of the binding pocket of MCL1.
<p>Surface representations are shown as side views and ligands are shown as yellow sticks. (A and B) Fragment 4 maps onto L78 of NoxaB from PDB ID 2NLA, with only minor structural perturbation of the BH3-binding groove of MCL1. In contrast, binding of fragment 6 creates a significant pocket (C) which is further expanded upon binding of ligand 1 (D).</p
Crystal packing of MCL1 173–321 is mediated by zinc and pyrophosphate.
<p>(A) The structure of MCL1 173–321 was determined to 1.70 Å. (B) In the ligand-bound MCL1 173–321 structure, the imidazole group of <b>1</b> coordinates with zinc along with H224 and pyrophosphate.</p